Efficacy and safety of Bruton’s tyrosine kinase inhibitors compared to Teriflunomide in relapsing multiple sclerosis: A systematic review and meta-analysis

Multiple Sclerosis and Related Disorders 2026

View at publisher

Authors: Milene Vitória Sampaio Sobral, Helen Michaela de Oliveira, Altair Pereira de Melo Neto, Thales Pardini Fagundes

DOI: 10.1016/j.msard.2026.106974

Cited by: 2

References: 34

Fields of Study & Subjects

Chronic Lymphocytic Leukemia Research Multiple Sclerosis Research Studies Acute Myeloid Leukemia Research

References 34